Abstract
Here we report the relationship between age at onset, clinical course and genotype in a family with combined LRRK2 G2019S and Parkin exon 2 deletions. In the combined mutation carriers the age at onset and clinical course was highly variable and not always younger than in the carriers of LRRK2 G2019S mutations alone.
Copyright (c) 2008 Elsevier Inc. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Age of Onset
-
Aged
-
DNA Mutational Analysis
-
Epistasis, Genetic / genetics
-
Exons / genetics
-
Female
-
Gene Dosage / genetics
-
Genetic Markers / genetics
-
Genetic Predisposition to Disease / genetics*
-
Genetic Testing
-
Genotype
-
Heterozygote
-
Humans
-
Inheritance Patterns / genetics
-
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
-
Male
-
Middle Aged
-
Mutation / genetics*
-
Parkinsonian Disorders / genetics*
-
Parkinsonian Disorders / physiopathology
-
Phenotype
-
Protein Serine-Threonine Kinases / genetics*
-
Ubiquitin-Protein Ligases / genetics*
-
Young Adult
Substances
-
Genetic Markers
-
Ubiquitin-Protein Ligases
-
parkin protein
-
LRRK2 protein, human
-
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
-
Protein Serine-Threonine Kinases